{"id":"triphosphate","_fda":{"id":"7e90559f-51b5-36ff-e053-2a91aa0a9b17","set_id":"119a205d-0074-48ff-ac78-e2300db45227","openfda":{"nui":["N0000193618","M0001797","N0000185375","N0000185371","N0000175629","N0000184306","M0000728","M0006342","M0016962","M0022575","N0000185017"],"upc":["0317089075202"],"unii":["8ID597Z82X","73Y7P0K73Y","OF5471ZHRR","8L70Q75FXE","PQ6CK8PD0R","CUQ3A77YXI","L7A49804ZQ","N487KM8COK","0UV74P3R0J","SAA04E81UX","K848JZ4886","88XHZ13131","33X04XA5AT","0E53J927NA","817L1N4CKP","VZ3U1H7Q5B","O138UB266J","68Y4CF58BV","TLM2976OFR","6CA025Y4FG","POD38AIF08","AB6MNQ6J6L","398IYQ16YV","9928MC12VO","M572600E5P"],"route":["ORAL"],"spl_id":["7e90559f-51b5-36ff-e053-2a91aa0a9b17"],"brand_name":["OMEOSPORT"],"spl_set_id":["119a205d-0074-48ff-ac78-e2300db45227"],"package_ndc":["17089-075-20"],"product_ndc":["17089-075"],"generic_name":[".ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO -"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Ascorbic Acid [CS]","Allergens [CS]","Dietary Proteins [CS]","Plant Proteins [CS]","Vegetable Proteins [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]"],"substance_name":[".ALPHA.-KETOGLUTARIC ACID",".ALPHA.-LIPOIC ACID","ACONITIC ACID, (Z)-","ADENOSINE TRIPHOSPHATE","ASCORBIC ACID","ASIAN GINSENG","BARIUM OXALOSUCCINATE","BEET","CEROUS OXALATE NONAHYDRATE","COENZYME A","CYSTEINE","FUMARIC ACID","LACTIC ACID","MAGNESIUM CARBONATE","MALIC ACID","MANGANESE PHOSPHATE, DIBASIC","PORK","PYRIDOXINE HYDROCHLORIDE","RIBOFLAVIN","SODIUM DIETHYL OXALACETATE","SODIUM PYRUVATE","SUCCINIC ACID","SUS SCROFA ADRENAL GLAND","SUS SCROFA EMBRYO","THIAMINE HYDROCHLORIDE"],"pharm_class_epc":["Vitamin C [EPC]","Non-Standardized Plant Allergenic Extract [EPC]","Non-Standardized Food Allergenic Extract [EPC]"],"manufacturer_name":["Guna spa"],"is_original_packager":[true]},"purpose":["USES For the temporary relief of symptoms related to athletic training and exertion such as: Muscle cramps Sore muscles Lack of endurance"],"version":"2","warnings":["WARNINGS Stop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children."],"questions":["QUESTIONS Questions?: info@gunainc.com tel. (484) 223-3500"],"effective_time":"20181221","active_ingredient":["ACTIVE INGREDIENTS/PURPOSE ADENOSINTRIPHOSPHATE 8X CELL METABOLISM ALPHA-KETOGLUTARIC ACID 6X DETOXIFICATION ALPHA-LIPOIC AC 6X DETOXIFICATION ASCORBIC ACID 4X CELL METABOLISM BARIUM OXALOSUCCINATE 6X DETOXIFICATION BETA VULGARIS 2X CELL METABOLISM CERIUM OXALICUM 6X CELL METABOLISM CIS-ACONITIC ACID 6X CELL METABOLISM COENZYME A 6X CELL METABOLISM CYSTEINUM 6X CELL METABOLISM EMBRYO EXTRACT 6X CELL METABOLISM FUMARICUM ACIDUM 6X ANTI-INFLAMMATORY GINSENG 3X DETOXIFICATION GLANDULA SUPRARENALIS 10X HORMONAL REGULATION LACTICUM ACIDUM 8X CELL METABOLISM MAGNESIUM CARBONATE 2X TIREDNESS MALIC ACID 6X CELL METABOLISM MANGANUM PHOSPHORICUM 6X TIREDNESS MUSCLE TISSUE 6X MUSCLE METABOLISM NATRUM OXALACETICUM 6X CELL METABOLISM NATRUM PYRUVICUM 6X CELL METABOLISM PYRIDOXINUM HYDROCHLORICUM 6X METABOLIC SUPPORT RIBOFLAVINUM 6X CELL METABOLISM SUCCINICUM ACIDUM 6X CELL METABOLISM THIAMINUM HYDROCHLORICUM 4X METABOLIC SUPPORT"],"inactive_ingredient":["Inactive ingredient: Sucrose."],"indications_and_usage":["Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals."],"dosage_and_administration":["DIRECTIONS Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be dissolved into a little water"],"spl_product_data_elements":["OMEOSPORT .ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO - SUCROSE ADENOSINE TRIPHOSPHATE ADENOSINE TRIPHOSPHATE .ALPHA.-KETOGLUTARIC ACID .ALPHA.-KETOGLUTARIC ACID .ALPHA.-LIPOIC ACID .ALPHA.-LIPOIC ACID ASCORBIC ACID ASCORBIC ACID BARIUM OXALOSUCCINATE BARIUM CATION BEET BEET CEROUS OXALATE NONAHYDRATE CEROUS CATION ACONITIC ACID, (Z)- ACONITIC ACID, (Z)- COENZYME A COENZYME A CYSTEINE CYSTEINE SUS SCROFA EMBRYO SUS SCROFA EMBRYO FUMARIC ACID FUMARIC ACID ASIAN GINSENG ASIAN GINSENG SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND LACTIC ACID LACTIC ACID MAGNESIUM CARBONATE CARBONATE ION MALIC ACID MALIC ACID MANGANESE PHOSPHATE, DIBASIC MANGANESE CATION (2+) PORK PORK SODIUM DIETHYL OXALACETATE DIETHYL OXALACETATE SODIUM PYRUVATE PYRUVIC ACID PYRIDOXINE HYDROCHLORIDE PYRIDOXINE RIBOFLAVIN RIBOFLAVIN SUCCINIC ACID SUCCINIC ACID THIAMINE HYDROCHLORIDE THIAMINE ION white"],"pregnancy_or_breast_feeding":["PREGNANCY If pregnant or breast-feeding ask a health professional before use."],"keep_out_of_reach_of_children":["WARNINGS Keep out of reach of children"],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL 5USBIO-Omeosport-rev04-110718"]},"safety":{"boxedWarnings":[],"commonSideEffects":[{"effect":"Constipation","drugRate":"3.6%","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"2.7%","severity":"common","organSystem":""},{"effect":"Abdominal Pain","drugRate":"1.4%","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Epigastric Pain","drugRate":"","severity":"common","organSystem":""}],"seriousAdverseEvents":[]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TRIPHOSPHATE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:17:41.160547+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:17:47.156392+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TRIPHOSPHATE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:17:47.482227+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:17:39.965196+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:17:39.965225+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:17:39.965229+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL473882/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:17:48.424403+00:00"}},"_dailymed":{"setId":"ddfb19cc-e77a-4d69-ad42-f4448faf0b47","title":"FOSTEUM PLUS (DICALCIUM MALATE, PENTACALCIUM HYDROXIDE TRIPHOSPHATE, PHOSPHATE, GENISTEIN AGLYCONE, CITRATED ZINC BISGLYCINATE, TRANS-MENAQUINONE-7, CHOLECALCIFEROL) CAPSULE [PRIMUS PHARMACEUTICALS, INC.]"},"mechanism":{"drugClass":"Vitamin C [EPC]"},"_scrapedAt":"2026-03-28T01:45:02.368Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:17:50.550212+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT03685721","phase":"","title":"Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-10-11","conditions":"Sickle Cell, PKLR Variants, Adenosine Triphosphate Activities","enrollment":800},{"nctId":"NCT03849651","phase":"PHASE2","title":"TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-01-31","conditions":"Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)","enrollment":69},{"nctId":"NCT06016387","phase":"PHASE2","title":"Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-11-25","conditions":"HER2-positive Breast Cancer, LMD","enrollment":30},{"nctId":"NCT05911906","phase":"PHASE4","title":"An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.","status":"COMPLETED","sponsor":"University of Derby","startDate":"2024-10-08","conditions":"SARS-CoV-2 Infection, COVID-19","enrollment":73},{"nctId":"NCT07252479","phase":"PHASE1","title":"Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations","status":"RECRUITING","sponsor":"Adlai Nortye Biopharma Co., Ltd.","startDate":"2026-01-28","conditions":"Solid Tumors (Phase 1), RAS Mutation","enrollment":91},{"nctId":"NCT06444477","phase":"","title":"Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2024-08-13","conditions":"Immune Thrombocytopenia, Immune Thrombocytopenic Purpura, Neoplasms","enrollment":33},{"nctId":"NCT05400109","phase":"PHASE1","title":"Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Wald","startDate":"2023-04-26","conditions":"Non Hodgkin Lymphoma","enrollment":21},{"nctId":"NCT04881240","phase":"PHASE1","title":"Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-02-14","conditions":"Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL","enrollment":60},{"nctId":"NCT07296354","phase":"PHASE4","title":"Evaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Egyptian International Pharmaceutical Industries Co","startDate":"2026-01-10","conditions":"Neuropathic Pain","enrollment":200},{"nctId":"NCT03119818","phase":"NA","title":"Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-06-14","conditions":"End-Stage Renal Disease (ESRD)","enrollment":11},{"nctId":"NCT05488431","phase":"PHASE2","title":"Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)","status":"RECRUITING","sponsor":"Priscilla Hsue, MD","startDate":"2023-03-01","conditions":"Dyslipidemias, Cardiovascular Diseases, HIV Infections","enrollment":121},{"nctId":"NCT06662760","phase":"PHASE1","title":"Clinical Trial of TQB3002 in Patients With Advanced Cancers","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-12-09","conditions":"Advanced Cancer","enrollment":150},{"nctId":"NCT05400122","phase":"PHASE1","title":"Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer","status":"SUSPENDED","sponsor":"David Wald","startDate":"2022-09-09","conditions":"Colorectal Cancer, Hematologic Malignancy, Rectum Cancer","enrollment":12},{"nctId":"NCT04897321","phase":"PHASE1","title":"B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-07-06","conditions":"Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma","enrollment":32},{"nctId":"NCT04318678","phase":"PHASE1","title":"CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2020-07-29","conditions":"AML/MDS, B-ALL, T-ALL","enrollment":108},{"nctId":"NCT06102525","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma","status":"RECRUITING","sponsor":"Rznomics, Inc.","startDate":"2024-10-08","conditions":"Glioblastoma","enrollment":43},{"nctId":"NCT07085975","phase":"PHASE1","title":"The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-08-05","conditions":"Chronic Cough (CC), Asthma","enrollment":33},{"nctId":"NCT06181799","phase":"","title":"Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-11-01","conditions":"Coronary Artery Disease, Ischemic Heart Disease, Chronic Coronary Disease","enrollment":80},{"nctId":"NCT05694260","phase":"PHASE2","title":"A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)","status":"COMPLETED","sponsor":"Esperion Therapeutics, Inc.","startDate":"2023-01-12","conditions":"Hypercholesterolemia","enrollment":31},{"nctId":"NCT04879368","phase":"PHASE3","title":"RegoNivo vs Standard of Care Chemotherapy in AGOC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2021-06-01","conditions":"Gastro-Oesophageal Cancer","enrollment":450},{"nctId":"NCT07059910","phase":"","title":"Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-07","conditions":"Immune Thrombocytopenic Purpura, Thyroid Disorders","enrollment":100},{"nctId":"NCT07064239","phase":"NA","title":"Effect of Cooling Vest in Multiple Sclerosis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-05-20","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT03675893","phase":"PHASE2","title":"RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-12-24","conditions":"Endometrial Cancer, Ovarian Cancer","enrollment":180},{"nctId":"NCT06893315","phase":"","title":"Photobiomodulation for Episiotomies and Perineal Lacerations After Vaginal Delivery.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Nove de Julho","startDate":"2024-09-01","conditions":"Perineal Lacerations, Delivery, Obstetric, Episiotomy Wound","enrollment":183},{"nctId":"NCT05265871","phase":"","title":"ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough","status":"COMPLETED","sponsor":"Kefang Lai","startDate":"2022-05-16","conditions":"Refractory/Unexplained Chronic Cough","enrollment":131},{"nctId":"NCT06112990","phase":"PHASE3","title":"Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-11-09","conditions":"Metastatic Prostate Cancer","enrollment":200},{"nctId":"NCT06921720","phase":"NA","title":"Phosphorus-31 Spectroscopy in Phosphate Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-05-01","conditions":"Phosphate Diabetes, X-linked Hypophosphatemia","enrollment":65},{"nctId":"NCT01276600","phase":"PHASE1","title":"Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2011-01","conditions":"HIV","enrollment":32},{"nctId":"NCT01827527","phase":"","title":"Magnetic Resonance & Optical Spectroscopy Validation","status":"RECRUITING","sponsor":"AdventHealth Translational Research Institute","startDate":"2013-03","conditions":"Validation Studies, Magnetic Resonance Spectroscopy","enrollment":150},{"nctId":"NCT06444009","phase":"PHASE2","title":"A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Lei Liu","startDate":"2024-07-01","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":90},{"nctId":"NCT04593680","phase":"NA","title":"Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thai Red Cross AIDS Research Centre","startDate":"2022-01-24","conditions":"Drug Interaction","enrollment":20},{"nctId":"NCT06676410","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2023-07-20","conditions":"HIV, HIV Infection","enrollment":40},{"nctId":"NCT03569813","phase":"NA","title":"Pre-exposure Prophylaxis (PrEP) at Home","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-04-26","conditions":"HIV/AIDS","enrollment":318},{"nctId":"NCT01782027","phase":"NA","title":"Mendelian Reverse Cholesterol Transport Study","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2012-10","conditions":"Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease","enrollment":17},{"nctId":"NCT03722849","phase":"NA","title":"Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough Patients","status":"COMPLETED","sponsor":"Stuart Mazzone","startDate":"2019-03-01","conditions":"Cough","enrollment":58},{"nctId":"NCT02056769","phase":"NA","title":"CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2014-04","conditions":"Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, Cerebral Vasospasm","enrollment":41},{"nctId":"NCT02756585","phase":"NA","title":"Computed Tomography Perfusion in Patients With Severe Head Injury","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2016-05-30","conditions":"Brain Injuries","enrollment":21},{"nctId":"NCT02102945","phase":"NA","title":"Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2014-06-09","conditions":"Brain Death","enrollment":5},{"nctId":"NCT01923922","phase":"NA","title":"CT Perfusion in the Prognostication of Cerebral High Grade Glioma","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2013-09-09","conditions":"Glioblastoma Multiforme","enrollment":48},{"nctId":"NCT06110598","phase":"PHASE2","title":"CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)","status":"WITHDRAWN","sponsor":"Case Comprehensive Cancer Center","startDate":"2024-12-01","conditions":"Pancreas Cancer, Pancreas Adenocarcinoma","enrollment":""},{"nctId":"NCT03800394","phase":"","title":"Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents","status":"COMPLETED","sponsor":"University of Florida","startDate":"2019-01-28","conditions":"Human Immunodeficiency Virus (HIV), Tuberculosis, Coinfection","enrollment":52},{"nctId":"NCT04336098","phase":"PHASE1","title":"Study of SRF617 in Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Coherus Oncology, Inc.","startDate":"2020-03-16","conditions":"Advanced Solid Tumor","enrollment":85},{"nctId":"NCT06434467","phase":"PHASE3","title":"The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-05","conditions":"T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma","enrollment":83},{"nctId":"NCT05354986","phase":"NA","title":"Impact of a Newly Formulated Toothpaste in Tooth Staining Associated With Chlorhexidine Rinses","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2022-10-01","conditions":"Tooth Staining, Periodontitis","enrollment":70},{"nctId":"NCT05459558","phase":"NA","title":"Clinical Study to Investigate the Tooth Stain Removal Efficacy of Two Experimental Toothpastes Compared to a Standard Toothpaste When Used Twice Daily for 8 Weeks","status":"COMPLETED","sponsor":"HALEON","startDate":"2022-09-15","conditions":"Oral Hygiene","enrollment":280},{"nctId":"NCT06363006","phase":"PHASE1","title":"Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-03-11","conditions":"Hepatocellular Carcinoma","enrollment":40},{"nctId":"NCT00159315","phase":"NA","title":"ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2002-10","conditions":"Asthma, COPD, Smoking","enrollment":31},{"nctId":"NCT06322355","phase":"","title":"Comparison of UFR With QFR in Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-07-01","conditions":"Coronary Artery Disease","enrollment":250},{"nctId":"NCT06266715","phase":"NA","title":"Improvement of Depression With Use of ATP","status":"RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-03-04","conditions":"Depression","enrollment":120},{"nctId":"NCT05926466","phase":"PHASE2","title":"BTZ-043 Dose Evaluation in Combination and Selection","status":"UNKNOWN","sponsor":"Michael Hoelscher","startDate":"2023-09-21","conditions":"Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis","enrollment":90},{"nctId":"NCT03412630","phase":"NA","title":"Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2018-12-13","conditions":"Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma","enrollment":1},{"nctId":"NCT03225105","phase":"PHASE1","title":"M3541 in Combination With Radiotherapy in Solid Tumors","status":"TERMINATED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2017-09-06","conditions":"Solid Tumors","enrollment":15},{"nctId":"NCT02693080","phase":"PHASE1","title":"CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-01-19","conditions":"Malignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung, Non-Small Cell Lung Carcinoma","enrollment":19},{"nctId":"NCT05431413","phase":"PHASE2","title":"Rapid Improvement of Depression of Fluoxetine Combined With ATP","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-01-07","conditions":"Depression","enrollment":195},{"nctId":"NCT05456269","phase":"PHASE1","title":"A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS","status":"WITHDRAWN","sponsor":"Race Oncology Ltd","startDate":"2022-07-29","conditions":"Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT01056523","phase":"PHASE1, PHASE2","title":"Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Jewish General Hospital","startDate":"2010-01","conditions":"Acute Myeloid Leukemia","enrollment":29},{"nctId":"NCT03699254","phase":"PHASE3","title":"Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.","status":"COMPLETED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2019-04-05","conditions":"Transplantation Infection, Cytomegalovirus Infections","enrollment":150},{"nctId":"NCT02858921","phase":"PHASE2","title":"Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma","status":"UNKNOWN","sponsor":"Melanoma Institute Australia","startDate":"2017-11-08","conditions":"Melanoma","enrollment":60},{"nctId":"NCT02960308","phase":"","title":"Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2016-10-20","conditions":"Head and Neck Neoplasm, Malignant Head and Neck Neoplasm","enrollment":49},{"nctId":"NCT03990623","phase":"NA","title":"CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization","status":"UNKNOWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-07-21","conditions":"Liver and Intrahepatic Bile Duct Carcinoma","enrollment":22},{"nctId":"NCT01387113","phase":"","title":"The PERFusion Use in Stroke Evaluation Study","status":"COMPLETED","sponsor":"California Pacific Medical Center Research Institute","startDate":"2011-05","conditions":"Ischemic Stroke","enrollment":48},{"nctId":"NCT05131191","phase":"","title":"CT-FFR for Coronary In-stent Stenosis Based on ISR-Net Algorithm","status":"UNKNOWN","sponsor":"Beijing Hospital","startDate":"2022-01-01","conditions":"Coronary Stent Occlusion","enrollment":150},{"nctId":"NCT05713019","phase":"NA","title":"ATP and P2X3 Receptor in Chronic Cough","status":"UNKNOWN","sponsor":"Imperial College London","startDate":"2023-02-28","conditions":"Cough","enrollment":20},{"nctId":"NCT04076761","phase":"PHASE2","title":"Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma","status":"TERMINATED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-12-11","conditions":"Cholangiocarcinoma, Bile Duct Cancer","enrollment":8},{"nctId":"NCT00415532","phase":"PHASE3","title":"Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura","status":"COMPLETED","sponsor":"Amgen","startDate":"2006-12-01","conditions":"Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)","enrollment":234},{"nctId":"NCT02987959","phase":"PHASE2","title":"Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas","status":"TERMINATED","sponsor":"Fox Chase Cancer Center","startDate":"2017-02-21","conditions":"Soft-tissue Sarcoma","enrollment":6},{"nctId":"NCT05536596","phase":"PHASE2, PHASE3","title":"Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy","status":"UNKNOWN","sponsor":"Universitat Internacional de Catalunya","startDate":"2022-09-30","conditions":"Retrognathism, Prognathism, Orthognathic Surgery","enrollment":220},{"nctId":"NCT05100589","phase":"NA","title":"Effect of PeakATP on Mood, Reaction Time and Cognition","status":"COMPLETED","sponsor":"University of Central Florida","startDate":"2021-10-06","conditions":"Cognitive Change, Mood","enrollment":35},{"nctId":"NCT02721537","phase":"NA","title":"Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-09","conditions":"Concussion, Mild","enrollment":30},{"nctId":"NCT04116606","phase":"PHASE2","title":"Antidepressant Trial With P2X7 Antagonist JNJ-54175446","status":"UNKNOWN","sponsor":"CCTU-Core","startDate":"2019-09-12","conditions":"Depressive Disorder, Major, Inflammation","enrollment":142},{"nctId":"NCT01306994","phase":"","title":"Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related Conditions","status":"WITHDRAWN","sponsor":"Freeman-Sheldon Research Group, Inc.","startDate":"2014-03","conditions":"Arthrogryposis, Craniofacial Abnormalities","enrollment":""},{"nctId":"NCT02528539","phase":"NA","title":"Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)","status":"COMPLETED","sponsor":"Huntington Memorial Hospital","startDate":"2013-08","conditions":"Lymphedema","enrollment":10},{"nctId":"NCT02626507","phase":"PHASE1","title":"Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer","status":"UNKNOWN","sponsor":"Hoffman Oncology","startDate":"2016-01","conditions":"Breast Cancer","enrollment":18},{"nctId":"NCT04509531","phase":"NA","title":"Building Resilience in Cyberbullying Victims","status":"COMPLETED","sponsor":"University of Deusto","startDate":"2020-09-15","conditions":"Cyberbullying, Depression, Non Suicidal Self Injury","enrollment":850},{"nctId":"NCT01220557","phase":"NA","title":"Evaluation of a Treatment and Education Programme for Type 1 Diabetic Patients (PRIMAS)","status":"COMPLETED","sponsor":"Forschungsinstitut der Diabetes Akademie Mergentheim","startDate":"2010-09","conditions":"Type 1 Diabetes","enrollment":160},{"nctId":"NCT03972683","phase":"EARLY_PHASE1","title":"Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training","status":"WITHDRAWN","sponsor":"Colorado State University","startDate":"2019-04-16","conditions":"Vasoconstriction, Vasodilation","enrollment":""},{"nctId":"NCT03738943","phase":"EARLY_PHASE1","title":"Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2019-02-07","conditions":"Receptor Blockade","enrollment":9},{"nctId":"NCT03167788","phase":"PHASE2","title":"Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery","status":"WITHDRAWN","sponsor":"University of Leicester","startDate":"2020-12","conditions":"Organ Failure, Multiple, Inflammation, Sepsis","enrollment":""},{"nctId":"NCT02472249","phase":"PHASE4","title":"Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2016-01","conditions":"Hepatocellular Carcinoma","enrollment":10},{"nctId":"NCT02281799","phase":"PHASE4","title":"Thiopurine Induced Pancreatitis in IBD Patients","status":"WITHDRAWN","sponsor":"Shaare Zedek Medical Center","startDate":"2015-03","conditions":"Pancreatitis, Inflammatory Bowel Diseases","enrollment":""},{"nctId":"NCT04744753","phase":"PHASE4","title":"AOA in Recurrent Fertilization Failure","status":"COMPLETED","sponsor":"MOHAMED BEHERY","startDate":"2017-07-15","conditions":"Infertility Primary","enrollment":150},{"nctId":"NCT00498719","phase":"","title":"Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer","status":"UNKNOWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2004-04","conditions":"Leukemia, Lymphoma, Brain Tumor","enrollment":30},{"nctId":"NCT03754192","phase":"NA","title":"Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-01-30","conditions":"Hepatocellular Carcinoma","enrollment":50},{"nctId":"NCT03456557","phase":"NA","title":"The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2018-03-07","conditions":"Acute Pancreatitis","enrollment":15},{"nctId":"NCT03647670","phase":"PHASE1","title":"A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-07-03","conditions":"Phase 1","enrollment":25},{"nctId":"NCT03662516","phase":"PHASE1","title":"A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-09-26","conditions":"Healthy Females","enrollment":17},{"nctId":"NCT02101918","phase":"PHASE2","title":"Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-06-18","conditions":"Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Carcinoma","enrollment":22},{"nctId":"NCT01386970","phase":"PHASE4","title":"Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2005-05","conditions":"HIV","enrollment":43},{"nctId":"NCT02619669","phase":"PHASE1","title":"Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer","status":"WITHDRAWN","sponsor":"Gary Schwartz","startDate":"2017-04-20","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT02580253","phase":"PHASE2","title":"Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation","status":"WITHDRAWN","sponsor":"Zhejiang University","startDate":"2017-11-01","conditions":"Hepatocellular Carcinoma","enrollment":""},{"nctId":"NCT03638063","phase":"","title":"ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2018-10-29","conditions":"Chronic Cough, Bronchiectasis","enrollment":200},{"nctId":"NCT04222543","phase":"PHASE2","title":"Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2019-11-22","conditions":"Oropharyngeal Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT00978250","phase":"PHASE2","title":"A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-08-20","conditions":"Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasms","enrollment":95},{"nctId":"NCT01499069","phase":"NA","title":"Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-02","conditions":"Overactive Bladder","enrollment":191},{"nctId":"NCT02789358","phase":"NA","title":"A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2015-12","conditions":"Atrial Fibrillation","enrollment":140},{"nctId":"NCT01072175","phase":"PHASE2","title":"Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-03-26","conditions":"Cancer","enrollment":430},{"nctId":"NCT03160703","phase":"NA","title":"Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-07-10","conditions":"Extrinsic Dental Stain, Oral Hygiene","enrollment":220},{"nctId":"NCT03477747","phase":"NA","title":"The Application of Microcurrent in Athletes","status":"COMPLETED","sponsor":"University of Greenwich","startDate":"2018-01-02","conditions":"Training Group, Sensitivity","enrollment":30},{"nctId":"NCT02659397","phase":"PHASE2","title":"A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg","status":"COMPLETED","sponsor":"Esperion Therapeutics, Inc.","startDate":"2015-12","conditions":"Hyperlipidemia","enrollment":68},{"nctId":"NCT02341456","phase":"PHASE1","title":"Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-01-16","conditions":"Advanced Solid Tumours","enrollment":19}],"_emaApprovals":[],"_faersSignals":[{"count":20,"reaction":"PYREXIA"},{"count":15,"reaction":"PLATELET COUNT DECREASED"},{"count":14,"reaction":"DIARRHOEA"},{"count":13,"reaction":"OFF LABEL USE"},{"count":12,"reaction":"PNEUMONIA"},{"count":11,"reaction":"DRUG INEFFECTIVE"},{"count":11,"reaction":"PRURITUS"},{"count":9,"reaction":"ANAEMIA"},{"count":9,"reaction":"DRUG ERUPTION"},{"count":9,"reaction":"TOXICITY TO VARIOUS AGENTS"}],"administration":{"route":"Oral"},"crossReferences":{"chemblId":"CHEMBL473882"},"_approvalHistory":[],"publicationCount":54737,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"TRIPHOSPHATE","genericName":"TRIPHOSPHATE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:17:50.550212+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}